Improved non-invasive imaging biomarkers of treatment response contribute to optimising cancer management and metabolites detected by proton magnetic resonance spectroscopy ((1)H MRS) show promise in this area. Understanding (1)H MRS changes occurring in cells during cell stress and cell death in vitro should aid the selection of pertinent biomarkers for clinical use.
|Number of pages||12|
|Journal||International Journal of Biochemistry and Cell Biology|
|Publication status||Published - 2011|
- Brain and Behaviour